Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.

Wang J, Yu M, Guo Q, Ma Q, Hu C, Ma Z, Yin X, Li X, Wang Y, Pan H, Wang D, Huang J, Meng H, Tong H, Qian W, Jin J.

Sci Rep. 2017 Apr 28;7:45960. doi: 10.1038/srep45960.

2.

Distal 7q11.23 Duplication, an Emerging Microduplication Syndrome: A Case Report and Further Characterisation.

Faundes V, Santa María L, Morales P, Curotto B, Parraguez MM.

Mol Syndromol. 2016 Oct;7(5):287-291. Epub 2016 Aug 24.

3.

Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.

Li Y, Min W, Li M, Han G, Dai D, Zhang L, Chen X, Wang X, Zhang Y, Yue Z, Liu J.

Int J Mol Med. 2016 Oct;38(4):1170-8. doi: 10.3892/ijmm.2016.2717. Epub 2016 Aug 26.

4.

A unique four-hub protein cluster associates to glioblastoma progression.

Simeone P, Trerotola M, Urbanella A, Lattanzio R, Ciavardelli D, Di Giuseppe F, Eleuterio E, Sulpizio M, Eusebi V, Pession A, Piantelli M, Alberti S.

PLoS One. 2014 Jul 22;9(7):e103030. doi: 10.1371/journal.pone.0103030. eCollection 2014.

5.

Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.

Talwar P, Silla Y, Grover S, Gupta M, Agarwal R, Kushwaha S, Kukreti R.

BMC Genomics. 2014 Mar 15;15:199. doi: 10.1186/1471-2164-15-199.

6.

Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases.

Ames HM, Wang AA, Coughran A, Evaul K, Huang S, Graves CW, Soyombo AA, Ross TS.

Mol Cell Biol. 2013 Sep;33(18):3580-93. doi: 10.1128/MCB.00473-13. Epub 2013 Jul 8.

7.

A genome-wide association study of aging.

Walter S, Atzmon G, Demerath EW, Garcia ME, Kaplan RC, Kumari M, Lunetta KL, Milaneschi Y, Tanaka T, Tranah GJ, Völker U, Yu L, Arnold A, Benjamin EJ, Biffar R, Buchman AS, Boerwinkle E, Couper D, De Jager PL, Evans DA, Harris TB, Hoffmann W, Hofman A, Karasik D, Kiel DP, Kocher T, Kuningas M, Launer LJ, Lohman KK, Lutsey PL, Mackenbach J, Marciante K, Psaty BM, Reiman EM, Rotter JI, Seshadri S, Shardell MD, Smith AV, van Duijn C, Walston J, Zillikens MC, Bandinelli S, Baumeister SE, Bennett DA, Ferrucci L, Gudnason V, Kivimaki M, Liu Y, Murabito JM, Newman AB, Tiemeier H, Franceschini N.

Neurobiol Aging. 2011 Nov;32(11):2109.e15-28. doi: 10.1016/j.neurobiolaging.2011.05.026. Epub 2011 Jul 22.

8.

Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit.

Ames HM, Bichakjian CK, Liu GY, Oravecz-Wilson KI, Fullen DR, Verhaegen ME, Johnson TM, Dlugosz AA, Ross TS.

J Invest Dermatol. 2011 Oct;131(10):2113-20. doi: 10.1038/jid.2011.171. Epub 2011 Jun 23.

9.

Transcription regulation of caspase-1 by R393 of HIPPI and its molecular partner HIP-1.

Banerjee M, Datta M, Majumder P, Mukhopadhyay D, Bhattacharyya NP.

Nucleic Acids Res. 2010 Jan;38(3):878-92. doi: 10.1093/nar/gkp1011. Epub 2009 Nov 24.

10.

Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis.

Pyrzynska B, Pilecka I, Miaczynska M.

Mol Oncol. 2009 Aug;3(4):321-38. doi: 10.1016/j.molonc.2009.06.001. Epub 2009 Jun 11. Review.

11.

Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.

Wang J, Yu W, Cai Y, Ren C, Ittmann MM.

Neoplasia. 2008 Aug;10(8):847-56.

12.

Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.

Graves CW, Philips ST, Bradley SV, Oravecz-Wilson KI, Li L, Gauvin A, Ross TS.

Cancer Res. 2008 Feb 15;68(4):1064-73. doi: 10.1158/0008-5472.CAN-07-5892.

Supplemental Content

Support Center